Activators of SPATA24 function within a complex network of signaling pathways to enhance its activity in spermatogenesis. Molecules that increase intracellular cAMP levels lead to the activation of protein kinase A (PKA), a key regulator in many cellular processes including sperm development. Sustained PKA activation through the use of cAMP analogs or inhibition of phosphodiesterases that degrade cAMP can result in the phosphorylation of downstream targets including SPATA24, thus promoting its role in spermatogenesis. Similarly, compounds that augment intracellular cGMP also serve to activate SPATA24. This is achieved either through inhibiting cGMP-specific phosphodiesterases, thereby maintaining elevated levels of cGMP, or by directly stimulating the enzymes that produce cGMP. The increase in cGMP levels can activate cGMP-dependent signaling mechanisms, which in turn can result in the activation of SPATA24, implicating its potential role in cGMP-mediated signaling events.
In addition to cyclic nucleotide pathways, calcium signaling also exerts influence over SPATA24 activity. Calcium ionophores and agonists of calcium channels elevate intracellular calcium concentrations, a second messenger critical in numerous cellular pathways, including those related to the maturation of sperm. This rise in calcium may activate calcium/calmodulin-dependent signaling cascades that can indirectly influence the activity of SPATA24. Furthermore, activation of protein kinase C (PKC) through specific activators can initiate a cascade of phosphorylation events, altering the function of proteins involved in spermatogenesis. Chemical chaperones that stabilize protein conformation and tyrosine kinase inhibitors that modify phosphorylation patterns also play roles in indirectly promoting the functional activity of SPATA24.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Elevates intracellular levels of cAMP which can enhance the PKA signaling pathway. SPATA24, being part of downstream cAMP signaling, is thus activated. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Phosphodiesterase inhibitor that prevents cAMP degradation, sustaining PKA activity. This prolongs the activation of downstream proteins including SPATA24. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
A cAMP analog that activates PKA. Sustained PKA activity can lead to the phosphorylation and activation of proteins like SPATA24 involved in sperm development. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $103.00 $245.00 | 8 | |
A cGMP-specific phosphodiesterase inhibitor which increases cGMP levels, potentially enhancing pathways that activate proteins such as SPATA24. | ||||||
L-Arginine | 74-79-3 | sc-391657B sc-391657 sc-391657A sc-391657C sc-391657D | 5 g 25 g 100 g 500 g 1 kg | $20.00 $30.00 $60.00 $215.00 $345.00 | 2 | |
Precursor of nitric oxide (NO) synthesis which can activate cGMP pathways, possibly resulting in the activation of cGMP-dependent proteins like SPATA24. | ||||||
YC-1 | 170632-47-0 | sc-202856 sc-202856A sc-202856B sc-202856C | 1 mg 5 mg 10 mg 50 mg | $32.00 $122.00 $214.00 $928.00 | 9 | |
Increases cGMP by activating soluble guanylyl cyclase, indirectly leading to the activation of cGMP-dependent proteins like SPATA24. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Ionophore that increases intracellular calcium levels, which may activate calcium/calmodulin-dependent pathways influencing the activity of SPATA24. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $82.00 $192.00 $801.00 | ||
L-type calcium channel agonist that increases intracellular calcium, potentially impacting calcium-dependent proteins including SPATA24. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC) which can modulate signaling pathways that include proteins involved in spermatogenesis like SPATA24. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
A tyrosine kinase inhibitor that can alter multiple signaling pathways, potentially leading to changes in the phosphorylation state and activation of SPATA24. | ||||||